MRI in monitoring the treatment of multiple sclerosis: concerted action guidelines.
Paty
D W
DW
Li
D K
DK
Koopmans
R
R
D001812:Blood-Brain Barrier / Q000502:physiology; D001921:Brain / Q000473:pathology; D003287:Contrast Media; D019786:Gadolinium DTPA; D006801:Humans; D008279:Magnetic Resonance Imaging / Q000379:methods*; D009103:Multiple Sclerosis / Q000175:diagnosis*; D009942:Organometallic Compounds / Q000009:adverse effects; D004369:Pentetic Acid / Q000009:adverse effects
D003287:Contrast Media; D009942:Organometallic Compounds; D004369:Pentetic Acid; D019786:Gadolinium DTPA